| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.09e-10 | 16 | 49 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.43e-09 | 21 | 49 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 VLDLR SLC8A1 FBN1 ENPP2 LRP1 LTBP2 LTBP3 RET LTBP4 LRP1B LDLR CRB2 | 1.98e-08 | 749 | 49 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | cargo receptor activity | 6.01e-08 | 85 | 49 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 3.53e-05 | 4 | 49 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.28e-05 | 172 | 49 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.56e-05 | 188 | 49 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.19e-04 | 39 | 49 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 3.83e-04 | 12 | 49 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 3.83e-04 | 12 | 49 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.78e-04 | 156 | 49 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.84e-04 | 17 | 49 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.09e-03 | 20 | 49 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.85e-03 | 26 | 49 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.85e-03 | 26 | 49 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.99e-03 | 27 | 49 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.01e-03 | 102 | 49 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 3.15e-03 | 34 | 49 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.33e-03 | 35 | 49 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.33e-03 | 35 | 49 | 2 | GO:0071814 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.43e-07 | 445 | 48 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 9.98e-07 | 337 | 48 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.44e-06 | 482 | 48 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | endocytosis | 2.34e-06 | 827 | 48 | 11 | GO:0006897 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 3.28e-06 | 276 | 48 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | import into cell | HSPG2 VLDLR LRP12 SLC8A1 DKK1 CD14 HAP1 LRP1 LRP5 LRP1B LDLR VAV2 | 4.56e-06 | 1074 | 48 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.19e-05 | 336 | 48 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FBN1 DKK1 HAP1 USP9X LRP1 LTBP2 LTBP3 RET USP9Y LTBP4 VAV2 CRB2 | 1.25e-05 | 1186 | 48 | 12 | GO:0007167 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.36e-05 | 343 | 48 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 2.11e-05 | 850 | 48 | 10 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.92e-05 | 883 | 48 | 10 | GO:0070848 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | HSPG2 SLC8A1 DKK1 HAP1 USP9X LRP1 LRP5 TRIM44 LDLR KLHL31 CRB2 | 3.12e-05 | 1088 | 48 | 11 | GO:0051248 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 5.28e-05 | 5 | 48 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 7.78e-05 | 309 | 48 | 6 | GO:1901888 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 8.00e-05 | 36 | 48 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 9.27e-05 | 197 | 48 | 5 | GO:0030509 | |
| GeneOntologyBiologicalProcess | action potential | 1.02e-04 | 201 | 48 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.11e-04 | 7 | 48 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.40e-04 | 215 | 48 | 5 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.40e-04 | 215 | 48 | 5 | GO:0071773 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.47e-04 | 8 | 48 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | amyloid fibril formation | 1.57e-04 | 45 | 48 | 3 | GO:1990000 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 2.46e-04 | 1141 | 48 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | AKAP6 VLDLR SLC8A1 FBN1 DKK1 ENPP2 LRP5 RET PPP6R2 LDLR KLHL31 | 3.37e-04 | 1421 | 48 | 11 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | AKAP6 VLDLR SLC8A1 FBN1 DKK1 ENPP2 LRP5 RET PPP6R2 LDLR KLHL31 | 3.41e-04 | 1423 | 48 | 11 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 3.45e-04 | 12 | 48 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 3.54e-04 | 1194 | 48 | 10 | GO:0000902 | |
| GeneOntologyBiologicalProcess | central nervous system development | 3.61e-04 | 1197 | 48 | 10 | GO:0007417 | |
| GeneOntologyBiologicalProcess | circulatory system development | AKAP6 HSPG2 SLC8A1 FBN1 DKK1 LRP1 LRP5 ADAM12 LDLR VAV2 CRB2 | 3.82e-04 | 1442 | 48 | 11 | GO:0072359 |
| GeneOntologyBiologicalProcess | neuron development | 4.32e-04 | 1463 | 48 | 11 | GO:0048666 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 4.74e-04 | 14 | 48 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | negative regulation of amyloid fibril formation | 4.74e-04 | 14 | 48 | 2 | GO:1905907 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | AKAP6 VLDLR SLC8A1 FBN1 DKK1 ENPP2 LRP5 RET PPP6R2 TRIM44 KLHL31 | 4.99e-04 | 1488 | 48 | 11 | GO:0031399 |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 5.58e-04 | 163 | 48 | 4 | GO:0008203 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 6.11e-04 | 167 | 48 | 4 | GO:0060048 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine catabolic process | 6.23e-04 | 16 | 48 | 2 | GO:0034638 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 6.23e-04 | 16 | 48 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | cholesterol import | 6.23e-04 | 16 | 48 | 2 | GO:0070508 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 7.05e-04 | 17 | 48 | 2 | GO:0098962 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 7.44e-04 | 176 | 48 | 4 | GO:1902652 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 7.60e-04 | 177 | 48 | 4 | GO:0016125 | |
| GeneOntologyBiologicalProcess | regulation of amyloid fibril formation | 8.84e-04 | 19 | 48 | 2 | GO:1905906 | |
| GeneOntologyBiologicalProcess | cell migration involved in gastrulation | 9.81e-04 | 20 | 48 | 2 | GO:0042074 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 1.06e-03 | 1133 | 48 | 9 | GO:0001932 | |
| GeneOntologyBiologicalProcess | relaxation of cardiac muscle | 1.08e-03 | 21 | 48 | 2 | GO:0055119 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.09e-03 | 87 | 48 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 1.17e-03 | 89 | 48 | 3 | GO:0055117 | |
| GeneOntologyBiologicalProcess | export from cell | 1.20e-03 | 1153 | 48 | 9 | GO:0140352 | |
| GeneOntologyBiologicalProcess | tube development | 1.24e-03 | 1402 | 48 | 10 | GO:0035295 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.24e-03 | 347 | 48 | 5 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.24e-03 | 202 | 48 | 4 | GO:0006937 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.24e-03 | 202 | 48 | 4 | GO:0051963 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.33e-03 | 93 | 48 | 3 | GO:0086003 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.66e-05 | 785 | 51 | 10 | GO:0098797 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 4.33e-05 | 80 | 51 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | receptor complex | 7.54e-05 | 581 | 51 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | membrane protein complex | AKAP6 HSPG2 CD14 SCN2A SCN10A LRP1 LRP5 RET C9 KCNB2 SSPOP CRB2 | 2.02e-04 | 1498 | 51 | 12 | GO:0098796 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.85e-04 | 530 | 51 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 4.47e-04 | 13 | 51 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | intercalated disc | 6.13e-04 | 68 | 51 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.75e-04 | 17 | 51 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | T-tubule | 9.49e-04 | 79 | 51 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.01e-03 | 656 | 51 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.03e-03 | 658 | 51 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | early endosome | 1.08e-03 | 481 | 51 | 6 | GO:0005769 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.57e-03 | 94 | 51 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.27e-03 | 29 | 51 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 2.57e-03 | 235 | 51 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.85e-03 | 583 | 51 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.51e-03 | 817 | 51 | 7 | GO:0098978 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 1.78e-05 | 2 | 22 | 2 | HP:0005900 | |
| HumanPheno | Hoarse voice | 4.15e-05 | 159 | 22 | 6 | HP:0001609 | |
| Domain | Ldl_recept_a | 2.16e-17 | 45 | 50 | 10 | PF00057 | |
| Domain | - | 2.75e-17 | 46 | 50 | 10 | 4.10.400.10 | |
| Domain | EGF_3 | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 C9 ADAM12 LTBP4 LRP1B SSPOP LDLR CRB2 | 3.05e-17 | 235 | 50 | 15 | PS50026 |
| Domain | LDLRA_1 | 4.39e-17 | 48 | 50 | 10 | PS01209 | |
| Domain | LDLRA_2 | 5.51e-17 | 49 | 50 | 10 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.51e-17 | 49 | 50 | 10 | IPR002172 | |
| Domain | LDLa | 5.51e-17 | 49 | 50 | 10 | SM00192 | |
| Domain | EGF_1 | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 C9 ADAM12 LTBP4 LRP1B SSPOP LDLR CRB2 | 1.04e-16 | 255 | 50 | 15 | PS00022 |
| Domain | EGF_2 | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 C9 ADAM12 LTBP4 LRP1B SSPOP LDLR CRB2 | 1.85e-16 | 265 | 50 | 15 | PS01186 |
| Domain | LDLR_class-A_CS | 8.47e-16 | 40 | 50 | 9 | IPR023415 | |
| Domain | EGF-like_dom | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 C9 ADAM12 LTBP4 LRP1B LDLR CRB2 | 2.38e-15 | 249 | 50 | 14 | IPR000742 |
| Domain | EGF-like_CS | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 C9 ADAM12 LTBP4 LRP1B LDLR CRB2 | 4.58e-15 | 261 | 50 | 14 | IPR013032 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 VLDLR FBN1 LRP1 LRP5 LTBP2 LTBP3 LTBP4 LRP1B LDLR CRB2 | 2.11e-14 | 124 | 50 | 11 | IPR001881 |
| Domain | EGF_CA | 9.47e-14 | 99 | 50 | 10 | PS01187 | |
| Domain | Growth_fac_rcpt_ | HSPG2 VLDLR TNFRSF9 FBN1 LRP1 LTBP2 LTBP3 C9 LTBP4 LRP1B LDLR | 2.73e-13 | 156 | 50 | 11 | IPR009030 |
| Domain | EGF_CA | 8.01e-13 | 122 | 50 | 10 | SM00179 | |
| Domain | EGF | HSPG2 VLDLR FBN1 NRXN2 LRP1 LRP5 LTBP2 LTBP3 LTBP4 LRP1B LDLR CRB2 | 9.46e-13 | 235 | 50 | 12 | SM00181 |
| Domain | EGF_Ca-bd_CS | 3.95e-12 | 97 | 50 | 9 | IPR018097 | |
| Domain | ASX_HYDROXYL | 5.23e-12 | 100 | 50 | 9 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.93e-12 | 106 | 50 | 9 | IPR000152 | |
| Domain | EGF_CA | 6.64e-11 | 86 | 50 | 8 | PF07645 | |
| Domain | Ldl_recept_b | 2.20e-10 | 14 | 50 | 5 | PF00058 | |
| Domain | LDLRB | 2.20e-10 | 14 | 50 | 5 | PS51120 | |
| Domain | LY | 3.29e-10 | 15 | 50 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.29e-10 | 15 | 50 | 5 | IPR000033 | |
| Domain | EGF | 1.45e-09 | 126 | 50 | 8 | PF00008 | |
| Domain | TB | 1.58e-09 | 7 | 50 | 4 | PF00683 | |
| Domain | - | 3.16e-09 | 8 | 50 | 4 | 3.90.290.10 | |
| Domain | TB | 5.67e-09 | 9 | 50 | 4 | PS51364 | |
| Domain | TB_dom | 5.67e-09 | 9 | 50 | 4 | IPR017878 | |
| Domain | - | 6.02e-08 | 39 | 50 | 5 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.41e-07 | 46 | 50 | 5 | IPR011042 | |
| Domain | cEGF | 6.50e-07 | 26 | 50 | 4 | IPR026823 | |
| Domain | cEGF | 6.50e-07 | 26 | 50 | 4 | PF12662 | |
| Domain | DUF5050 | 7.02e-06 | 2 | 50 | 2 | IPR032485 | |
| Domain | DUF5050 | 7.02e-06 | 2 | 50 | 2 | PF16472 | |
| Domain | Laminin_G | 1.73e-05 | 58 | 50 | 4 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 1.43e-04 | 38 | 50 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.66e-04 | 40 | 50 | 3 | PF02210 | |
| Domain | LamG | 2.21e-04 | 44 | 50 | 3 | SM00282 | |
| Domain | Na_channel_asu | 3.12e-04 | 10 | 50 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.12e-04 | 10 | 50 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.12e-04 | 10 | 50 | 2 | PF06512 | |
| Domain | EGF_extracell | 5.55e-04 | 60 | 50 | 3 | IPR013111 | |
| Domain | EGF_2 | 5.55e-04 | 60 | 50 | 3 | PF07974 | |
| Domain | - | 2.10e-03 | 95 | 50 | 3 | 2.60.120.200 | |
| Domain | hEGF | 2.54e-03 | 28 | 50 | 2 | PF12661 | |
| Domain | ConA-like_dom | 2.78e-03 | 219 | 50 | 4 | IPR013320 | |
| Domain | Ion_trans_dom | 3.52e-03 | 114 | 50 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.52e-03 | 114 | 50 | 3 | PF00520 | |
| Domain | zf-RING_2 | 8.55e-03 | 52 | 50 | 2 | PF13639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.27e-06 | 8 | 41 | 3 | M47850 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.09e-06 | 32 | 41 | 4 | MM14854 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.74e-06 | 77 | 41 | 5 | MM14670 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.79e-06 | 37 | 41 | 4 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 4.23e-06 | 38 | 41 | 4 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.71e-06 | 39 | 41 | 4 | MM14601 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 6.40e-06 | 13 | 41 | 3 | M42551 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 7.34e-06 | 94 | 41 | 5 | M1041 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.68e-06 | 44 | 41 | 4 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.00e-05 | 47 | 41 | 4 | M646 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.09e-05 | 48 | 41 | 4 | M27642 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.16e-05 | 381 | 41 | 8 | M48063 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.22e-05 | 118 | 41 | 5 | MM15588 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.23e-05 | 300 | 41 | 7 | M610 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.31e-05 | 258 | 41 | 6 | MM14572 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 9.82e-05 | 161 | 41 | 5 | M27871 | |
| Pathway | REACTOME_SIGNALING_BY_LRP5_MUTANTS | 1.23e-04 | 6 | 41 | 2 | M27432 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.97e-04 | 100 | 41 | 4 | M27158 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 2.29e-04 | 8 | 41 | 2 | MM14976 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.58e-04 | 198 | 41 | 5 | M18311 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 8.46e-04 | 15 | 41 | 2 | M27273 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 8.46e-04 | 15 | 41 | 2 | M42552 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 1.23e-03 | 18 | 41 | 2 | M42559 | |
| Pathway | WP_STATIN_PATHWAY | 1.37e-03 | 19 | 41 | 2 | MM15868 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 1.84e-03 | 22 | 41 | 2 | M42574 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 2.01e-03 | 23 | 41 | 2 | M48234 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.11e-10 | 21 | 51 | 5 | 21337463 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 18367731 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.36e-09 | 101 | 51 | 6 | 23382219 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 15611103 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 15863833 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.19e-08 | 4 | 51 | 3 | 11104663 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 15840700 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 18685438 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 8013374 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 30700132 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12746448 | ||
| Pubmed | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo. | 2.96e-08 | 5 | 51 | 3 | 18992221 | |
| Pubmed | Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. | 2.96e-08 | 5 | 51 | 3 | 23959870 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 16478678 | ||
| Pubmed | 6.71e-08 | 71 | 51 | 5 | 33541421 | ||
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 10930463 | ||
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 12169628 | ||
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 10380922 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 2.48e-07 | 9 | 51 | 3 | 7544347 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 20005821 | ||
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 24639464 | ||
| Pubmed | 8.56e-07 | 118 | 51 | 5 | 21078624 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 LRP12 FBN1 LRP1 LRP5 LTBP2 LTBP3 PPP6R2 ADAM12 LRP1B LDLR | 1.07e-06 | 1201 | 51 | 11 | 35696571 |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 15082773 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.07e-06 | 14 | 51 | 3 | 17389516 | |
| Pubmed | 1.33e-06 | 15 | 51 | 3 | 33722956 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.70e-06 | 248 | 51 | 6 | 24006456 | |
| Pubmed | RET signaling is required for survival and normal function of nonpeptidergic nociceptors. | 2.11e-06 | 2 | 51 | 2 | 20237269 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 2.11e-06 | 2 | 51 | 2 | 15963947 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 2.11e-06 | 2 | 51 | 2 | 26494287 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19393635 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17889283 | ||
| Pubmed | Control of lung development by latent TGF-β binding proteins. | 2.11e-06 | 2 | 51 | 2 | 20945348 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17223614 | ||
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 2.11e-06 | 2 | 51 | 2 | 11971949 | |
| Pubmed | A practical overview of pediatric atopic dermatitis, part 2: triggers and grading. | 2.11e-06 | 2 | 51 | 2 | 27274543 | |
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 2.11e-06 | 2 | 51 | 2 | 12690199 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.11e-06 | 2 | 51 | 2 | 12895410 | |
| Pubmed | Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women. | 2.11e-06 | 2 | 51 | 2 | 24736728 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 7798248 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 2.11e-06 | 2 | 51 | 2 | 24484584 | |
| Pubmed | Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. | 2.11e-06 | 2 | 51 | 2 | 16245025 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30306291 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24867584 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8922996 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9449704 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15923613 | ||
| Pubmed | Microfibrils at basement membrane zones interact with perlecan via fibrillin-1. | 2.11e-06 | 2 | 51 | 2 | 15657057 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28252045 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17505534 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9602168 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20063381 | ||
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 2.11e-06 | 2 | 51 | 2 | 29625025 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10024503 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23104139 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12925892 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11516963 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11108739 | ||
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 2.11e-06 | 2 | 51 | 2 | 15327526 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34831326 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 38545339 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17700537 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10575007 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20101398 | ||
| Pubmed | CD14 and IL4R gene polymorphisms modify the effect of day care attendance on serum IgE levels. | 2.11e-06 | 2 | 51 | 2 | 19447482 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32514132 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17709443 | ||
| Pubmed | Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization. | 2.11e-06 | 2 | 51 | 2 | 24058663 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8636110 | ||
| Pubmed | 2.39e-06 | 18 | 51 | 3 | 10827173 | ||
| Pubmed | 2.45e-06 | 146 | 51 | 5 | 27068509 | ||
| Pubmed | 5.93e-06 | 175 | 51 | 5 | 28071719 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23846497 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19667105 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21730304 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26323289 | ||
| Pubmed | High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo. | 6.32e-06 | 3 | 51 | 2 | 25808845 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21489615 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15842262 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30100244 | ||
| Pubmed | RAGE, LDL receptor, and LRP1 expression in the brains of SAMP8. | 6.32e-06 | 3 | 51 | 2 | 19539695 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11931574 | ||
| Pubmed | Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. | 6.32e-06 | 3 | 51 | 2 | 17201240 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23675525 | ||
| Pubmed | Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking. | 6.32e-06 | 3 | 51 | 2 | 26147533 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20301776 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 14739216 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10488949 | ||
| Pubmed | LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages. | 6.32e-06 | 3 | 51 | 2 | 26061292 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18250411 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15258195 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 1423604 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19742316 | ||
| Pubmed | mTOR inhibition rescues osteopenia in mice with systemic sclerosis. | 6.32e-06 | 3 | 51 | 2 | 25534817 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25546260 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26224810 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18277139 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31796057 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19746449 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 14583618 | ||
| Interaction | ZNF408 interactions | 2.08e-09 | 145 | 49 | 8 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 2.62e-07 | 57 | 49 | 5 | int:ZFP41 | |
| Interaction | NTN5 interactions | 3.16e-07 | 24 | 49 | 4 | int:NTN5 | |
| Interaction | IGFL3 interactions | 1.05e-06 | 75 | 49 | 5 | int:IGFL3 | |
| Interaction | FOXD4L6 interactions | 6.03e-06 | 49 | 49 | 4 | int:FOXD4L6 | |
| Interaction | CACNA1A interactions | 1.20e-05 | 123 | 49 | 5 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 1.30e-05 | 125 | 49 | 5 | int:ZDHHC15 | |
| Interaction | CLU interactions | 2.74e-05 | 245 | 49 | 6 | int:CLU | |
| Interaction | PRG2 interactions | 6.37e-05 | 285 | 49 | 6 | int:PRG2 | |
| Interaction | WNT10A interactions | 9.90e-05 | 37 | 49 | 3 | int:WNT10A | |
| Cytoband | 10q11.2 | 1.09e-04 | 14 | 51 | 2 | 10q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.63e-03 | 454 | 51 | 4 | chr11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.27e-03 | 234 | 51 | 3 | chr8p23 | |
| Cytoband | 11q13.4 | 3.19e-03 | 75 | 51 | 2 | 11q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 6.03e-03 | 104 | 51 | 2 | chr2p22 | |
| GeneFamily | Low density lipoprotein receptors | 1.34e-13 | 13 | 40 | 6 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 4.01e-08 | 4 | 40 | 3 | 628 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.70e-04 | 9 | 40 | 2 | 1203 | |
| GeneFamily | Ring finger proteins | 3.11e-03 | 275 | 40 | 4 | 58 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.68e-03 | 51 | 40 | 2 | 870 | |
| GeneFamily | Ubiquitin specific peptidases | 6.82e-03 | 56 | 40 | 2 | 366 | |
| Coexpression | BMI1_DN.V1_UP | 3.64e-07 | 147 | 50 | 6 | M2782 | |
| Coexpression | NABA_CORE_MATRISOME | 7.79e-07 | 270 | 50 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 8.81e-07 | 275 | 50 | 7 | M5884 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 4.95e-06 | 681 | 50 | 9 | M5314 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 6.39e-06 | 703 | 50 | 9 | MM1055 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.17e-05 | 191 | 50 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.58e-05 | 196 | 50 | 5 | M3008 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 3.75e-05 | 34 | 50 | 3 | M14043 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 3.85e-05 | 199 | 50 | 5 | M8105 | |
| Coexpression | DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS | 4.86e-05 | 105 | 50 | 4 | M40242 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP | 9.58e-05 | 125 | 50 | 4 | M15672 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.20e-04 | 50 | 50 | 3 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.35e-04 | 52 | 50 | 3 | MM1118 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.37e-04 | 137 | 50 | 4 | M40313 | |
| Coexpression | MEL18_DN.V1_UP | 1.52e-04 | 141 | 50 | 4 | M2784 | |
| Coexpression | BMI1_DN_MEL18_DN.V1_UP | 1.70e-04 | 145 | 50 | 4 | M2779 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 1.74e-04 | 274 | 50 | 5 | M289 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | 2.16e-04 | 1106 | 50 | 9 | M39071 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.15e-05 | 455 | 46 | 7 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 5.76e-05 | 97 | 46 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.98e-05 | 466 | 46 | 7 | GSM777050_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.38e-04 | 369 | 46 | 6 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 2.22e-04 | 403 | 46 | 6 | GSM605853_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 2.33e-04 | 990 | 46 | 9 | JC_fibro_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 2.37e-04 | 408 | 46 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 2.38e-04 | 778 | 46 | 8 | gudmap_kidney_adult_RenalCapsule_1000 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.93e-09 | 199 | 51 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-08 | 189 | 51 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-08 | 190 | 51 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-08 | 191 | 51 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-08 | 191 | 51 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-08 | 192 | 51 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-08 | 195 | 51 | 6 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 198 | 51 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.09e-07 | 200 | 51 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.74e-07 | 149 | 51 | 5 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-06 | 162 | 51 | 5 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 174 | 51 | 5 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 181 | 51 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 181 | 51 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-06 | 182 | 51 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-06 | 185 | 51 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.30e-06 | 186 | 51 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 187 | 51 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 188 | 51 | 5 | 2cfa41c64eccb28b5e22f0f91bbc921b75713245 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 188 | 51 | 5 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 189 | 51 | 5 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 189 | 51 | 5 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 51 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-06 | 190 | 51 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 190 | 51 | 5 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.62e-06 | 191 | 51 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 191 | 51 | 5 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 191 | 51 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 191 | 51 | 5 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 192 | 51 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 192 | 51 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 192 | 51 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 192 | 51 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.69e-06 | 192 | 51 | 5 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-06 | 192 | 51 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 192 | 51 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 192 | 51 | 5 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-06 | 193 | 51 | 5 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 193 | 51 | 5 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 193 | 51 | 5 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.76e-06 | 193 | 51 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 193 | 51 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 193 | 51 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-06 | 194 | 51 | 5 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.83e-06 | 194 | 51 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-06 | 194 | 51 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 195 | 51 | 5 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 195 | 51 | 5 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-06 | 195 | 51 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 195 | 51 | 5 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 195 | 51 | 5 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 195 | 51 | 5 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 196 | 51 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 196 | 51 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 196 | 51 | 5 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-06 | 196 | 51 | 5 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-06 | 197 | 51 | 5 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 198 | 51 | 5 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 199 | 51 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | mLN-(5)_Dendritic_cell|mLN / shred on region, Cell_type, and subtype | 3.21e-06 | 199 | 51 | 5 | 4feecf533e29a1a558f1018a2e8f7bfa7b9d3864 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 199 | 51 | 5 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | mLN-Dendritic_cell|mLN / Region, Cell class and subclass | 3.21e-06 | 199 | 51 | 5 | 597412beae1324b9c43ca2bb96c4cb645c19f3e9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 199 | 51 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 199 | 51 | 5 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 199 | 51 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 199 | 51 | 5 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 199 | 51 | 5 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-06 | 200 | 51 | 5 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Control-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.19e-06 | 104 | 51 | 4 | 5f72aa686b0fb83d401621e1b9d9c69e56105570 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.06e-05 | 141 | 51 | 4 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-05 | 142 | 51 | 4 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 153 | 51 | 4 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 154 | 51 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-05 | 158 | 51 | 4 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-05 | 163 | 51 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.63e-05 | 163 | 51 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.63e-05 | 163 | 51 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.72e-05 | 164 | 51 | 4 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.90e-05 | 166 | 51 | 4 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 167 | 51 | 4 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 167 | 51 | 4 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 170 | 51 | 4 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 170 | 51 | 4 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 170 | 51 | 4 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 170 | 51 | 4 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.28e-05 | 170 | 51 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 170 | 51 | 4 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 171 | 51 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 172 | 51 | 4 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 172 | 51 | 4 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 173 | 51 | 4 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.58e-05 | 173 | 51 | 4 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| Computational | Metal / Ca ion binding. | 6.48e-05 | 133 | 35 | 5 | MODULE_324 | |
| Computational | Placenta genes. | 9.39e-05 | 463 | 35 | 8 | MODULE_38 | |
| Computational | Ovary genes. | 1.53e-04 | 368 | 35 | 7 | MODULE_1 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 5.43e-04 | 453 | 35 | 7 | MODULE_24 | |
| Computational | Genes in the cancer module 55. | 1.07e-03 | 832 | 35 | 9 | MODULE_55 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.35e-03 | 384 | 35 | 6 | MODULE_2 | |
| Computational | Genes in the cancer module 236. | 1.53e-03 | 18 | 35 | 2 | MODULE_236 | |
| Drug | monatepil | 4.32e-07 | 29 | 49 | 4 | CID000060810 | |
| Drug | fenoxycarb | 7.97e-07 | 80 | 49 | 5 | CID000051605 | |
| Drug | probucol | 1.28e-06 | 162 | 49 | 6 | CID000004912 | |
| Drug | CS-0398 | 2.41e-06 | 44 | 49 | 4 | CID005288149 | |
| Drug | funiferine N-oxide | 3.73e-06 | 49 | 49 | 4 | CID000191631 | |
| Drug | SorbPC | 4.54e-06 | 2 | 49 | 2 | CID006439169 | |
| Drug | ezetimibe | 1.59e-05 | 147 | 49 | 5 | CID000150311 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.71e-05 | 4 | 49 | 2 | ctd:C501880 | |
| Drug | 4-hydroxybenzylamine | 2.71e-05 | 4 | 49 | 2 | CID000097472 | |
| Drug | N,N-dibenzylphenylethanolamine | 2.71e-05 | 4 | 49 | 2 | CID000048896 | |
| Drug | vitamin E | 4.15e-05 | 441 | 49 | 7 | CID000002116 | |
| Drug | AC1NAG0I | 4.45e-05 | 32 | 49 | 3 | CID004476319 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 4.55e-05 | 183 | 49 | 5 | 6946_UP | |
| Drug | epicholesterol | 5.82e-05 | 636 | 49 | 8 | CID000000304 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 6173_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 3298_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 4705_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 4758_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 5541_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 6759_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 2761_UP | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 5939_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5469_UP | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 4661_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 3821_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4311_UP | |
| Drug | APETx1, Anthopleura elegantissima | 6.77e-05 | 6 | 49 | 2 | ctd:C475726 | |
| Drug | fenpropathrin | 6.77e-05 | 6 | 49 | 2 | ctd:C044267 | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 200 | 49 | 5 | 2894_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HG-U133A | 6.93e-05 | 200 | 49 | 5 | 1915_DN | |
| Drug | phosphorylcholine | 7.10e-05 | 201 | 49 | 5 | CID000001014 | |
| Drug | Vanadates | HSPG2 VLDLR SLC8A1 TNFRSF9 USP9X ENPP2 LRP1 LTBP2 LTBP3 USP9Y ADAM12 | 7.98e-05 | 1302 | 49 | 11 | ctd:D014638 |
| Drug | Epi Lovastatin | 8.78e-05 | 341 | 49 | 6 | CID000003962 | |
| Drug | AC1NAL8H | 9.43e-05 | 41 | 49 | 3 | CID004478772 | |
| Drug | ethyl lactate | 9.46e-05 | 7 | 49 | 2 | CID000007344 | |
| Drug | pitavastatin | 1.06e-04 | 114 | 49 | 4 | CID005282451 | |
| Drug | troglitazone | 1.25e-04 | 526 | 49 | 7 | CID000005591 | |
| Drug | tesmilifene | 1.26e-04 | 8 | 49 | 2 | ctd:C043062 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.26e-04 | 8 | 49 | 2 | ctd:C489827 | |
| Drug | AC1L1J6H | 1.51e-04 | 236 | 49 | 5 | CID000004889 | |
| Drug | bupivacaine | 1.52e-04 | 125 | 49 | 4 | CID000002474 | |
| Drug | Technetium-exametazime | 2.02e-04 | 10 | 49 | 2 | CID009577951 | |
| Disease | aortic measurement | 3.25e-06 | 251 | 48 | 6 | EFO_0020865 | |
| Disease | Weill-Marchesani syndrome | 7.77e-06 | 3 | 48 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 7.77e-06 | 3 | 48 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 7.77e-06 | 3 | 48 | 2 | C1869114 | |
| Disease | inflammatory biomarker measurement | 1.02e-05 | 26 | 48 | 3 | EFO_0004872 | |
| Disease | Weill-Marchesani syndrome | 1.55e-05 | 4 | 48 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.55e-05 | 4 | 48 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | FEV/FEC ratio | 2.32e-05 | 1228 | 48 | 10 | EFO_0004713 | |
| Disease | Geleophysic dysplasia | 2.58e-05 | 5 | 48 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 2.58e-05 | 5 | 48 | 2 | C0265287 | |
| Disease | cholesteryl ester 16:2 measurement | 5.41e-05 | 7 | 48 | 2 | EFO_0021435 | |
| Disease | obsolete aging | 8.95e-05 | 279 | 48 | 5 | GO_0007568 | |
| Disease | aortic aneurysm | 1.16e-04 | 10 | 48 | 2 | EFO_0001666 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Marfan Syndrome | 1.41e-04 | 11 | 48 | 2 | C0024796 | |
| Disease | Shortened QT interval | 1.41e-04 | 11 | 48 | 2 | C0151879 | |
| Disease | epilepsy (implicated_via_orthology) | 1.44e-04 | 163 | 48 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Mitral valve prolapse, response to surgery | 1.69e-04 | 12 | 48 | 2 | EFO_0009951, HP_0001634 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | stenosing tenosynovitis | 1.69e-04 | 12 | 48 | 2 | EFO_0010822 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.05e-04 | 70 | 48 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.05e-04 | 70 | 48 | 3 | C3241937 | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 2.33e-04 | 14 | 48 | 2 | DOID:898 (is_marker_for) | |
| Disease | S-6-hydroxywarfarin measurement | 3.24e-04 | 368 | 48 | 5 | EFO_0803326 | |
| Disease | Van Buchem disease | 3.47e-04 | 17 | 48 | 2 | C0432272 | |
| Disease | cortical thickness | 3.94e-04 | 1113 | 48 | 8 | EFO_0004840 | |
| Disease | colorectal cancer | 4.24e-04 | 604 | 48 | 6 | MONDO_0005575 | |
| Disease | periodontitis | 4.76e-04 | 223 | 48 | 4 | EFO_0000649 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.82e-04 | 447 | 48 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | carotid artery intima media thickness | 8.05e-04 | 450 | 48 | 5 | EFO_0007117 | |
| Disease | methionine measurement | 8.21e-04 | 26 | 48 | 2 | EFO_0009771 | |
| Disease | Colorectal Carcinoma | 9.31e-04 | 702 | 48 | 6 | C0009402 | |
| Disease | suicidal ideation | 1.02e-03 | 29 | 48 | 2 | EFO_0004320 | |
| Disease | rhinitis (is_implicated_in) | 1.09e-03 | 30 | 48 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | spontaneous coronary artery dissection | 1.17e-03 | 31 | 48 | 2 | EFO_0010820 | |
| Disease | alkaline phosphatase measurement | 1.20e-03 | 1015 | 48 | 7 | EFO_0004533 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.31e-03 | 132 | 48 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.32e-03 | 33 | 48 | 2 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | intraocular pressure measurement | 1.39e-03 | 509 | 48 | 5 | EFO_0004695 | |
| Disease | Thyroid Gland Follicular Adenoma | 1.49e-03 | 35 | 48 | 2 | C0151468 | |
| Disease | ascending aortic diameter | 1.55e-03 | 140 | 48 | 3 | EFO_0021787 | |
| Disease | pulmonary tuberculosis (is_marker_for) | 1.58e-03 | 36 | 48 | 2 | DOID:2957 (is_marker_for) | |
| Disease | Mitral valve prolapse | 1.58e-03 | 36 | 48 | 2 | HP_0001634 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVEEGEECDCGEPEE | 431 | O43184 | |
| QCTLCGEPEEEEAGD | 26 | Q9P1A6 | |
| EDEVFDDSICPTNCD | 1531 | Q96MT7 | |
| YIDSDCIGNPDEDCE | 611 | Q6ZMN7 | |
| GDFDCEDRTDEANCP | 346 | P98160 | |
| FHCDEESDCPDRSDE | 386 | P98160 | |
| EDDELPEATVGVSCC | 596 | Q9H511 | |
| GNIDCLDLGDEIDCD | 241 | Q9Y561 | |
| CDGERDCPDGSDELS | 2781 | Q9NZR2 | |
| CSEEDGPKEEDCSQD | 321 | Q9H089 | |
| AGPTCEEDVDECLSD | 351 | Q5IJ48 | |
| DCGDGSDEEDCSIDP | 3766 | Q07954 | |
| DGFPECDDQSDEEGC | 1281 | O75197 | |
| ETATDCPEVLEEGCE | 266 | Q6ZNL6 | |
| CVDEDLEPTCFERSD | 21 | P31512 | |
| AECPSDDEDLEECEP | 1401 | Q9P2S2 | |
| ASEEEEDPTFCEVCG | 176 | Q9P1Y6 | |
| ECPSDDEDLEECEPS | 356 | P58401 | |
| CQAERDDSDCEEPIE | 431 | P58401 | |
| TPEPCELDDEDFRCV | 21 | P08571 | |
| CVELFEAPVECEEEE | 361 | P24394 | |
| EREGEEFDNTCCPDK | 161 | Q92953 | |
| DEDRCCELPASRDGE | 1041 | Q9P218 | |
| CEDIDECVEEPEICA | 2011 | P35555 | |
| LSGEEEDDEPDCCND | 131 | Q6P158 | |
| EEEAEEDLQCAHPCD | 281 | P54257 | |
| EDGTACEDLDECAFP | 1086 | Q14767 | |
| DSCEDVDECEDPQSS | 1131 | Q14767 | |
| SPESGECVDIDECED | 1251 | Q14767 | |
| DIDECDFPAACIGGD | 826 | Q9NS15 | |
| RLECIDNDECADEEP | 1291 | Q8N2S1 | |
| DNDECADEEPACEGG | 1296 | Q8N2S1 | |
| AEDEECGTDEYCASP | 86 | O94907 | |
| DDDCEEIKAAECPAG | 146 | Q13822 | |
| TEPCEDAEDDCGNDF | 91 | P02748 | |
| ACCSDRIQPFDDDED | 621 | O75170 | |
| ECPFPGDTEEEVFDC | 756 | Q6P5Z2 | |
| EPDLEDEQVCCEALE | 1276 | Q93008 | |
| ELPHDGTCDECEPDE | 11 | Q96DX7 | |
| CDRQDDCGDGTDEPS | 1436 | A2VEC9 | |
| FEACVEGDSDGEEPC | 2156 | Q13023 | |
| IFSPCSDCEEEEEEE | 26 | P30291 | |
| ILEDPFECNDSGEDC | 111 | Q6ZN79 | |
| QLGEEAEGEEFCPCE | 1646 | Q8IWN7 | |
| DDLEEPDDCFTEGCI | 1106 | Q9Y5Y9 | |
| EGLPEACDDLELADD | 461 | Q8N5U6 | |
| PEESLEPEACFTEDC | 1161 | Q99250 | |
| QEEDGCSCRFPEEEE | 236 | Q07011 | |
| LCDGELDCPLGEDEE | 76 | Q9NRS4 | |
| ACELCPEEEPDDQDA | 2471 | O00507 | |
| ILEDPFECNDSGEDC | 111 | A8MWA4 | |
| ILEDPFECNDSGEDC | 111 | A8MUZ8 | |
| CFPEEEKCFCEPEDI | 611 | P07949 | |
| EHDLGEDIYDCVPCE | 151 | P52735 | |
| QDDCSDGSDELDCAP | 176 | P98155 | |
| DRDCLDGSDEASCPV | 131 | P01130 | |
| DDDECGEEKLPSCFD | 761 | P32418 |